Results 11 to 20 of about 5,191 (294)

In vitro evaluation of mesalazine enteric-coated tablet dissolution by the reciprocating cylinder method [PDF]

Scientific Reports
Mesalazine formulations are first-line treatments for ulcerative colitis. However, the drug release mechanisms of currently available mesalazine formulations on the market vary, and different in vitro dissolution methods have been used to characterize ...
Jinxiang Wang, Yanqing Zhao, Gaihua He, Bin Guo, Hui Zhang   +4 more
doaj   +2 more sources

Development of pH-Sensitive Multiparticulates for Orally Disintegrating Tablets of Proton Pump Inhibitors: Physicochemical Characterization and Drug Release Studies [PDF]

Pharmaceutics
Background/Objectives: Enteric coating protects active pharmaceutical ingredients from gastric degradation, but conventional tablets may present swallowing difficulties in geriatric and pediatric patients.
Mahendra Singh, Punna Reddy Ullapu, Arokia Vijaya Anand Mariadoss, Satyender Kumar, Sung Gu Kang   +4 more
doaj   +2 more sources

Pharmacokinetics and bioequivalence study of esomeprazole magnesium enteric-coated tablets 20 mg in healthy Chinese subjects under fasting and fed conditions. [PDF]

Front Pharmacol, 2023
Ding Y, Chu N, Que L, Huang K, Chen Y, Qin W, Qian Z, Shi Y, Xu Z, He Q.   +9 more
europepmc   +3 more sources

Application of Thin-Layer Chromatography in Combination with Densitometry for the Determination of Diclofenac in Enteric Coated Tablets. [PDF]

Pharmaceuticals (Basel), 2019
Parys W, Pyka-Pająk A, Dołowy M.
europepmc   +3 more sources

Acupoint Injection Combined with BCG-PSN and Thymosin Enteric-Coated Tablets Improve China Han Psoriasis Vulgaris by Regulating T Cell Subsets. [PDF]

Psoriasis (Auckl)
Li J, Zhao X, Pan H, Duan Y, Li W, Zhao Y, Yao L, Zhang K.   +7 more
europepmc   +3 more sources

In Silico Evaluation of the Biopharmaceutical and Pharmacokinetic Behavior of Metronidazole from Coated Colonic Release Matrix Tablets [PDF]

Pharmaceutics
Background: Physiologically based biopharmaceutics modeling (PBBM) models can help to predict drug release and in vivo absorption behaviors. Colon drug delivery systems have gained interest over the past few years due to the advantages they provide in ...
Roberto Arévalo-Pérez, Cristina Maderuelo, José M. Lanao   +2 more
doaj   +2 more sources

Enteric Coated Tablet Dosage Form [PDF]

, 2020
National Cancer Institute
openalex   +2 more sources

Enteric-Coated Zoledronic Acid Tablet MER-101 [PDF]

, 2020
National Cancer Institute
openalex   +2 more sources

Case report: Alectinib-associated intestinal ulceration and colitis in a patient with non-small cell lung cancer and effective treatment with Mesalazine [PDF]

Pathology and Oncology Research
BackgroundAlectinib is effective in extending the survival of patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) and generally has manageable side effects.
Zijian Qiu, Fei Ke, Xiaoping Zhu
doaj   +2 more sources

Modulation of mesalamine release from enteric-coated matrix tablets using natural polysaccharides for localized colonic delivery

Journal of Applied Pharmaceutical Research
Background: Inflammatory bowel diseases (IBD) require effective colon-targeted drug delivery for improved therapeutic efficacy and minimized systemic side effects.
Shilpa Sahu, Prasanta Kumar Choudhury, Gourishyam Pasa, Padala Narasimha Murthy, Poonam Sahu, Renuka Verma   +5 more
doaj   +3 more sources